ESOPred

Prediction of Risk of Metastasis and Deregulated Oncogenic Signaling Pathways in Esophageal Cancer.

Our innovative product, the Prediction of Risk of Metastasis in Esophageal Cancer Patients Based on High Resolution H&E Histopathological Images Using Deep Learning, represents a significant advancement in the field of oncology. Esophageal cancer is a highly aggressive malignancy with a propensity for metastasis. Our solution address this challenge by harnessing the power of deep learning algorithms to analyze highresolution H&E histopathological images of esophageal cancer tumors.